Advertisement
U.S. markets open in 21 minutes

VolitionRx Limited (VNRX)

NYSE American - NYSE American Delayed Price. Currency in USD
1.0500+0.0100 (+0.96%)
At close: 04:00PM EST
1.0500 0.00 (0.00%)
After hours: 06:17PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close1.0400
Open1.0400
Bid1.0000 x 2900
Ask1.0800 x 2900
Day's Range1.0300 - 1.0800
52 Week Range0.5500 - 2.1000
Volume47,360
Avg. Volume230,760
Market Cap82.62M
Beta (5Y Monthly)1.43
PE Ratio (TTM)N/A
EPS (TTM)-0.5200
Earnings DateMar 13, 2024 - Mar 18, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.76
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for VNRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VolitionRX Limited
    Analyst Report: General Electric CompanyGE was formed through the combination of two companies in 1892, including one with historical ties to American inventor Thomas Edison. Today, GE is a global leader in air travel and in the energy transition. The company is known for its differentiated technology and its massive industrial installed base of equipment sprawled throughout the world. That installed base most notably includes aerospace engines, gas and steam turbines, and onshore and offshore wind turbines. GE earns most of its profits on the service revenue of that equipment, which is generally higher-margin. The company is led by Danaher alumnus Larry Culp, who is leading GE through a breakup of its businesses.
    Rating
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more
  • PR Newswire

    Volition to Share Nu.Q® NETs Strategy Update at Upcoming Webinar

    VolitionRx Limited (NYSE American: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison Group, to update stakeholders on recent developments and ongoing studies for its Nu.Q® NETs test.

  • InvestorPlace

    Next Big Thing: 3  Biotech Stocks to Watch for Groundbreaking Advances

    The International Monetary Fund believes that most of the impact from tighter money policies has already affected the U.S. economy, with the rest expected this year. Despite worries about a recession, the U.S. has shown resilience and strong growth since interest rates started going up in March 2022. This suggests a positive outlook for the U.S. economy in the coming months. With our economy, looking to perform well this year you need to invest in these biotech stocks that will provide high retu

  • PR Newswire

    Volition Issues Business Review 2023

    VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has issued a Business Review of 2023, outlining its key highlights from the past year.